Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2563910, 9 pages
https://doi.org/10.1155/2017/2563910
Research Article

Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses

1Department of Electronic Engineering, National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan
2Department of Chemical Engineering & Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan
3Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
4Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
5Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
6Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
7Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
8Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan
9Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
10Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Correspondence should be addressed to Yi-Chen Lee; wt.ude.umk@38nehciy and Hsueh-Wei Chang; wt.ude.umk@whgnahc

Received 12 April 2016; Accepted 28 November 2016; Published 4 January 2017

Academic Editor: Franco M. Buonaguro

Copyright © 2017 Cheng-Hong Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Ibrahim, M. E. Al-Foheidi, M. M. Al-Mansour, and G. A. Kazkaz, “The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis,” Breast Cancer Research and Treatment, vol. 148, no. 3, pp. 467–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. Z.-Y. Yang, M.-Y. Di, J.-Q. Yuan et al., “The prognostic value of phosphorylated Akt in breast cancer: a systematic review,” Scientific Reports, vol. 5, article no. 7758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. N. Stevens, C. M. Vachon, and F. J. Couch, “Genetic susceptibility to triple-negative breast cancer,” Cancer Research, vol. 73, no. 7, pp. 2025–2030, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. W.-P. Chang, M.-E. Liu, W.-C. Chang et al., “Sleep apnea and the subsequent risk of breast cancer in women: a nationwide population-based cohort study,” Sleep Medicine, vol. 15, no. 9, pp. 1016–1020, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thurlimann, and H. J. Senn, “Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007,” Annals of Oncology, vol. 18, no. 7, pp. 1133–1144, 2007. View at Publisher · View at Google Scholar
  6. N. J. Bundred, “Prognostic and predictive factors in breast cancer,” Cancer Treatment Reviews, vol. 27, no. 3, pp. 137–142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Ohno-Machado, “Modeling medical prognosis: survival analysis techniques,” Journal of Biomedical Informatics, vol. 34, no. 6, pp. 428–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Ludwig and J. N. Weinstein, “Biomarkers in cancer staging, prognosis and treatment selection,” Nature Reviews Cancer, vol. 5, no. 11, pp. 845–856, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-S. F. Yuan, M.-F. Hou, Y.-C. Hsieh et al., “Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer,” Journal of the National Cancer Institute, vol. 104, no. 19, pp. 1485–1502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-J. Wang, H. Frånbergh-Karlson, D.-W. Wang, G. Arbman, H. Zhang, and X.-F. Sun, “Clinicopathological significance of BTF3 expression in colorectal cancer,” Tumor Biology, vol. 34, no. 4, pp. 2141–2146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Robertson and M. H. Zweig, “Use of receiver operating characteristic curves to evaluate the clinical-performance of analytical systems,” Clinical Chemistry, vol. 27, no. 9, pp. 1569–1574, 1981. View at Google Scholar · View at Scopus
  12. M. H. Zweig and G. Campbell, “Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine,” Clinical Chemistry, vol. 39, no. 4, pp. 561–577, 1993. View at Google Scholar · View at Scopus
  13. J. Gu, S. Ghosal, and A. Roy, “Bayesian bootstrap estimation of ROC curve,” Statistics in Medicine, vol. 27, no. 26, pp. 5407–5420, 2008. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  14. C.-Y. Yen, C.-H. Chen, C.-H. Chang et al., “Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers,” Biomarkers, vol. 14, no. 4, pp. 244–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-Y. Yen, C.-Y. Huang, M.-F. Hou et al., “Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC),” Biomarkers, vol. 18, no. 1, pp. 63–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. I.-M. Shih, “Application of human leukocyte antigen-G expression in the diagnosis of human cancer,” Human Immunology, vol. 68, no. 4, pp. 272–276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Jin, D. S. Daly, J. R. Marks, and R. C. Zangar, “Oxidatively modified proteins as plasma biomarkers in breast cancer,” Cancer Biomarkers, vol. 13, no. 3, pp. 193–200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Baskic, S. Popovic, D. Bankovic et al., “Evaluation of inflammatory biomarkers as helping diagnostic tool in patients with breast cancer,” Cancer Biomarkers, vol. 14, no. 6, pp. 401–408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhao, M. Wang, C. Cui et al., “Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma,” Cancer Biomarkers, vol. 15, no. 5, pp. 677–683, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Qin, G. Liu, X. Huo et al., “Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma,” Cancer Biomarkers, vol. 16, no. 1, pp. 161–169, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Hanley and B. J. McNeil, “A method of comparing the areas under receiver operating characteristic curves derived from the same cases,” Radiology, vol. 148, no. 3, pp. 839–843, 1983. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Sotiriou, S.-Y. Neo, L. M. McShane et al., “Breast cancer classification and prognosis based on gene expression profiles from a population-based study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10393–10398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-C. Tseng, C.-Y. Pan, S.-T. Chou et al., “Treatment of adult Class III malocclusions with orthodontic therapy or orthognathic surgery: receiver operating characteristic analysis,” American Journal of Orthodontics and Dentofacial Orthopedics, vol. 139, no. 5, pp. e485–e493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. A. El-Mezayen, F. M. Metwally, and H. Darwish, “A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer,” Tumor Biology, vol. 35, no. 3, pp. 2759–2767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Rozalski, D. Gackowski, A. Siomek-Gorecka et al., “Urinary 5-hydroxymethyluracil and 8-oxo-7,8-dihydroguanine as potential biomarkers in patients with colorectal cancer,” Biomarkers, vol. 20, no. 5, pp. 287–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. De Paoli, P. Perco, I. Mühlberger et al., “Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic,” Biomarkers, vol. 20, no. 5, pp. 328–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Walker and A. M. Thompson, Prognostic and Predictive Factors in Breast Cancer, Informa Healthcare, London, UK, 2008.
  28. G. D'Eredita', C. Giardina, M. Martellotta, T. Natale, and F. Ferrarese, “Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution,” European Journal of Cancer, vol. 37, no. 5, pp. 591–596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. S. Rampaul, S. E. Pinder, C. W. Elston, and I. O. Ellis, “Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team,” European Journal of Surgical Oncology, vol. 27, no. 3, pp. 229–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Jimenez-Lee, B. Ham, J. Vetto, and R. Pommier, “Breast cancer severity score is an innovative system for prognosis,” American Journal of Surgery, vol. 186, no. 4, pp. 404–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Yanai, Y. Miyagawa, K. Murase et al., “Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers,” International Journal of Clinical Oncology, vol. 19, no. 3, pp. 467–472, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Biglia, E. Peano, P. Sgandurra et al., “Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women,” Gynecological Endocrinology, vol. 29, no. 3, pp. 263–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Loi, N. Sirtaine, F. Piette et al., “Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98,” Journal of Clinical Oncology, vol. 31, no. 7, pp. 860–867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Cetin and M. Topcul, “Triple negative breast cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2427–2431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-H. Yang, H.-W. Chang, Y.-H. Cheng, and L.-Y. Chuang, “Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization,” Cancer Epidemiology, vol. 33, no. 2, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. N. Wang, C. H. Cheng, and H. W. Chiu, “Predicting post-treatment survivability of patients with breast cancer using Artificial Neural Network methods,” in Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2013), pp. 1290–1293, Osaka, Japan, July 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-H. Yang, Y.-D. Lin, L.-Y. Chuang, J.-B. Chen, and H.-W. Chang, “MDR-ER: balancing functions for adjusting the ratio in risk classes and classification errors for imbalanced cases and controls using multifactor-dimensionality reduction,” PLoS ONE, vol. 8, no. 11, Article ID e79387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. C.-H. Yang, L.-Y. Chuang, Y.-J. Chen, H.-F. Tseng, and H.-W. Chang, “Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study,” OMICS, vol. 15, no. 6, pp. 399–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. H.-W. Chang, L.-Y. Chuang, C.-H. Ho, P.-L. Chang, and C.-H. Yang, “Odds ratio-based genetic algorithms for generating SNP barcodes of genotypes to predict disease susceptibility,” OMICS A Journal of Integrative Biology, vol. 12, no. 1, pp. 71–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C.-H. Yang, Y.-D. Lin, C.-Y. Yen, L.-Y. Chuang, and H.-W. Chang, “A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk,” OMICS, vol. 19, no. 4, pp. 238–247, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. C.-H. Yang, L.-Y. Chuang, Y.-H. Cheng et al., “Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms,” Kaohsiung Journal of Medical Sciences, vol. 28, no. 7, pp. 362–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. L.-Y. Chuang, H.-W. Chang, M.-C. Lin, and C.-H. Yang, “Chaotic particle swarm optimization for detecting SNP-SNP interactions for CXCL12-related genes in breast cancer prevention,” European Journal of Cancer Prevention, vol. 21, no. 4, pp. 336–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. L.-Y. Chuang, Y.-D. Lin, H.-W. Chang, and C.-H. Yang, “An improved PSO algorithm for generating protective SNP barcodes in breast cancer,” PLoS ONE, vol. 7, no. 5, Article ID e37018, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Kourou, T. P. Exarchos, K. P. Exarchos, M. V. Karamouzis, and D. I. Fotiadis, “Machine learning applications in cancer prognosis and prediction,” Computational and Structural Biotechnology Journal, vol. 13, pp. 8–17, 2015. View at Publisher · View at Google Scholar · View at Scopus